These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1192008)

  • 1. Editorial: Blood transfusion and iron overload.
    Br Med J; 1975 Nov; 4(5991):244-5. PubMed ID: 1192008
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum ferritin in children with thalassaemia regularly transfused.
    Letsky EA; Miller F; Worwood M; Flynn DM
    J Clin Pathol; 1974 Aug; 27(8):652-5. PubMed ID: 4421996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Controlled desferrioxamine treatment of congenital anaemia and transfusion siderosis (author's transl)].
    Arnold H; Wehinger H; Deus B; Löhr GW
    Dtsch Med Wochenschr; 1978 Aug; 103(31):1240-4. PubMed ID: 668572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High dosage desferrioxamine therapy in a female patient with acquired aplastic anaemia and transfusion siderosis.
    Breithaupt H; Heckers H; Pralle H; Guttmann W; Bleyl H; Graef V; Jundt G
    Blut; 1986 Apr; 52(4):211-9. PubMed ID: 3634632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host-associated iron transfer factor in normal humans and patients with transfusion siderosis.
    Jones RL; Grady RW; Sorette MP; Cerami A
    J Lab Clin Med; 1986 May; 107(5):431-8. PubMed ID: 3701190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current concepts in the overall management of thalassemia.
    Propper RD
    Ann N Y Acad Sci; 1980; 344():375-83. PubMed ID: 6930877
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduction of iron overload in thalassemia.
    Piomelli S; Graziano J
    Birth Defects Orig Artic Ser; 1982; 18(7):339-46. PubMed ID: 7159742
    [No Abstract]   [Full Text] [Related]  

  • 8. Dl-alpha-tocopherol, iron, and lipofuscin in thalassemia.
    Hyman CB; Landing B; Alfin-Slater R; Kozak L; Weitzman J; Ortega JA
    Ann N Y Acad Sci; 1974; 232(0):211-20. PubMed ID: 4528518
    [No Abstract]   [Full Text] [Related]  

  • 9. Iron overload--clinical and pathologic aspects.
    Jacobs A
    Semin Hematol; 1977 Jan; 14(1):89-113. PubMed ID: 318770
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathophysiology and treatment of iron overload in thalassemia patients in tropical countries.
    Marx JJ
    Adv Exp Med Biol; 2003; 531():57-68. PubMed ID: 12916781
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical trial of desferrioxamine entrapped in red cell ghosts.
    Green R; Lamon J; Curran D
    Lancet; 1980 Aug; 2(8190):327-30. PubMed ID: 6105474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron deficiency and iron overload.
    Jacobs A
    Crit Rev Oncol Hematol; 1985; 3(2):143-86. PubMed ID: 3896543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Computer tomographic detection of iron-storing lymph nodes in transfusion requiring anemias].
    König R; Brendlein F
    Rofo; 1982 Sep; 137(3):350-2. PubMed ID: 6216169
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial: Thalassemia major: a problem of iron overload.
    Stockman JA; Oski FA
    Ann Intern Med; 1974 Aug; 81(2):262-3. PubMed ID: 4846109
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic liver disease in transfusion-dependent thalassemia: liver iron quantitation and distribution.
    De Virgiliis S; Cornacchia G; Sanna G; Argiolu F; Galanello R; Fiorelli G; Rais M; Cossu P; Bertolino F; Cao A
    Acta Haematol; 1981; 65(1):32-9. PubMed ID: 6791435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current status of treatments with desferrioxamine B in post-transfusion hypersiderosis in children].
    Orsini A; Raybaud C; Bernard PJ; Aquaron R; Passeron P
    Mars Med; 1967; 104(4):331-7. PubMed ID: 5621537
    [No Abstract]   [Full Text] [Related]  

  • 17. Current strategies in the management of Cooley's anemia.
    Piomelli S; Hart D; Graziano J; Grant G; Karpatkin M; McCarthy K
    Ann N Y Acad Sci; 1985; 445():256-67. PubMed ID: 3860128
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnosis and treatment of cardiac iron overload in transfusion-dependent thalassemia patients.
    Siri-Angkul N; Chattipakorn SC; Chattipakorn N
    Expert Rev Hematol; 2018 Jun; 11(6):471-479. PubMed ID: 29754517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. THE TREATMENT OF IRON OVERLOAD WITH DESFERRIOXAMINE B.
    NORMAN CS
    Ir J Med Sci; 1964 Jan; 457():13-8. PubMed ID: 14113899
    [No Abstract]   [Full Text] [Related]  

  • 20. Glutathione S-transferase gene polymorphism: Relation to cardiac iron overload in Egyptian patients with Beta Thalassemia Major.
    Mokhtar GM; Sherif EM; Habeeb NM; Abdelmaksoud AA; El-Ghoroury EA; Ibrahim AS; Hamed EM
    Hematology; 2016 Jan; 21(1):46-53. PubMed ID: 26288192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.